
View larger version (15K):
[in a new window]
|
Figure 3. Plot of mean values for dosearea product (DAP) to effective dose (ED) conversion factors derived from different studies; Hart and Wall 1994 [14] x , Gelijns et al 1997 [16] , Ruiz-Cruces et al 2000 [15] +, Kemerink et al 2001 [17] , Lampinen and Rannikko 1999 [18] , together with factors related to tube potential from Martin and Hunter 1994 [4] (solid line), and for a posteroanterior (PA) pelvis projection from Hart et al 1996 [13] (dashed line).
|